These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2941985)

  • 1. Familial combined hyperlipidemia. Part I. Lipid values and the lipoprotein pattern.
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1986; 113():193-216. PubMed ID: 2941985
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined familial hyperlipidemia. Study of a family].
    Ahumada-Ayala M; Lozano-Castañeda O; Rull JA; Valles VE; Wong B
    Rev Invest Clin; 1984; 36(2):141-5. PubMed ID: 6484332
    [No Abstract]   [Full Text] [Related]  

  • 3. [Familial combined hyperlipidemia. I. Variation in the lipoprotein picture].
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Vnitr Lek; 1986 Sep; 32(9):878-86. PubMed ID: 3765425
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of familial combined hyperlipidemia in 11 families.
    Das SK; Chandra M; Shukla RN; Nityanand S; Agarwal SS
    Indian J Med Res; 1983 Nov; 78():665-9. PubMed ID: 6671713
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin concentrations in patients with combined hyperlipidemia: relationship to serum lipids and lipoproteins.
    Haluzík M; Fiedler J; Nedvídková J; Ceska R
    Physiol Res; 1999; 48(5):363-8. PubMed ID: 10625225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid composition of high density lipoproteins in familial hyperlipoproteinemias].
    Tvorogova MG; Vasin PN; Rozhkova TA; Kukharchuk VV; Titov VN
    Vopr Med Khim; 1998; 44(5):452-8. PubMed ID: 9916260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents].
    Ribalta J; La Ville AE; Heras M; Plana N; Masana L
    Med Clin (Barc); 1997 Jun; 109(5):161-4. PubMed ID: 9289537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
    Grundy SM; Vega GL; Yuan Z; Battisti WP; Brady WE; Palmisano J
    Am J Cardiol; 2005 Feb; 95(4):462-8. PubMed ID: 15695129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet, smoking, and blood lipids in patients with combined familial hyperlipidaemia.
    Králíková E; Ceska R; Rames J
    Cent Eur J Public Health; 1999 Feb; 7(1):19-23. PubMed ID: 10084016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric victims of unexplained stroke and their families: familial lipid and lipoprotein abnormalities.
    Glueck CJ; Daniels SR; Bates S; Benton C; Tracy T; Third JL
    Pediatrics; 1982 Mar; 69(3):308-16. PubMed ID: 6977760
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial combined hyperlipidemia].
    de Bruin TW; Dallinga-Thie GM; Erkelens DW
    Ned Tijdschr Geneeskd; 1996 Oct; 140(43):2118-21. PubMed ID: 8965962
    [No Abstract]   [Full Text] [Related]  

  • 18. Status of "familial combined hyperlipidemia".
    Brunzell JD; Motulsky AG
    Prog Clin Biol Res; 1984; 147():403-5. PubMed ID: 6739492
    [No Abstract]   [Full Text] [Related]  

  • 19. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
    Arca M; Natoli S; Micheletta F; Riggi S; Di Angelantonio E; Montali A; Antonini TM; Antonini R; Diczfalusy U; Iuliano L
    Free Radic Biol Med; 2007 Mar; 42(5):698-705. PubMed ID: 17291993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.